Credit Suisse Ag Abb Vie Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Abb Vie Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 2,736,828 shares of ABBV stock, worth $467 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

2,736,828

Previous 2,635,132 3.86%

Holding current value

$467 Million

Previous $408 Million 22.04%

% of portfolio

0.49%

Previous 0.4%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $16.3 Million - $18.5 Million	101,696 Added 3.86%	2,736,828 $498 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $47.7 Million - $53.7 Million	-346,693 Reduced 11.63%	2,635,132 $408 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $2.05 Million - $2.37 Million	-15,309 Reduced 0.51%	2,981,825 $444 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $719,131 - $894,912	5,427 Added 0.18%	2,997,134 $404 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $38.1 Million - $43.8 Million	-263,199 Reduced 8.09%	2,991,707 $477 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $15.8 Million - $19 Million	114,451 Added 3.64%	3,254,906 $526 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $8.32 Million - $9.54 Million	-62,003 Reduced 1.94%	3,140,455 $421 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $19.1 Million - $24.3 Million	-139,055 Reduced 4.16%	3,202,458 $490 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $1.8 Million - $2.23 Million	13,623 Added 0.41%	3,341,513 $542 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $36.1 Million - $45.7 Million	-336,278 Reduced 9.18%	3,327,890 $451 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $19.4 Million - $22.1 Million	182,734 Added 5.25%	3,664,168 $395 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $89.9 Million - $100 Million	-854,124 Reduced 19.7%	3,481,434 $391 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $15.2 Million - $16.8 Million	-149,061 Reduced 3.32%	4,335,558 $469 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $11.1 Million - $14.9 Million	-137,453 Reduced 2.97%	4,484,619 $481 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $13.1 Million - $15.4 Million	-152,914 Reduced 3.2%	4,622,072 $405 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $46.9 Million - $62.7 Million	638,876 Added 15.45%	4,774,986 $469 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $96.9 Million - $147 Million	-1,502,724 Reduced 26.65%	4,136,110 $315 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $1.38 Million - $1.72 Million	-19,064 Reduced 0.34%	5,638,834 $499 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $184 Million - $221 Million	2,917,243 Added 106.44%	5,657,898 $428 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $30.2 Million - $38.6 Million	459,895 Added 20.16%	2,740,655 $199 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $79.4 Million - $93.4 Million	-1,029,202 Reduced 31.09%	2,280,760 $184 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $59.4 Million - $73.3 Million	763,248 Added 29.97%	3,309,962 $305 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $8.5 Million - $9.45 Million	-95,645 Reduced 3.62%	2,546,714 $241 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $18.6 Million - $22 Million	-206,670 Reduced 7.25%	2,642,359 $245 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $27.4 Million - $36.7 Million	-297,943 Reduced 9.47%	2,849,029 $270 Million
Q4 2017 Mar 14, 2018	BUY	$89.56 - $98.21 $21.5 Million - $23.6 Million	240,600 Added 8.28%	3,146,972 $304 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $33.5 Million - $36.7 Million	-373,996 Reduced 11.4%	2,906,372 $281 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $13.4 Million - $17.2 Million	-192,552 Reduced 5.54%	3,280,368 $291 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,472,920	3,472,920 $252 Million

Others Institutions Holding ABBV

# of Institutions

3,869

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account